Seeking AlphaSat, 09 May 2026 21:51:18 GMTBioVie Inc. (BIVI) Discusses Bezisterim's Mechanism of Action and Its Potential in Addressing Parkinson's Disease Pathology TranscriptBIVI-4.55%
Seeking AlphaThu, 05 Mar 2026 08:22:11 GMTBioVie Inc. (BIVI) Discusses Clinical Progress of Bezisterim Targeting Inflammation in Parkinson's, Alzheimer's, and Long COVID TranscriptBIVI-4.55%